SoftWave Tissue Regeneration Technologies, a medical device company specializing in extracorporeal shockwave therapy, will utilize DataBiologics to track outcomes on their device.
DataBiologics will empower a select group of physicians utilizing the SoftWave device to participate in a real-world evidence study on the clinical outcomes of these innovative treatments.
"We are excited to partner with DataBiologics as SoftWave is on the cutting edge of regenerative medicine and we are looking forward to documenting our incredible patient outcomes,” said John Warlick, CEO of SoftWave. "SoftWave is used by leading physicians and DataBiologics’ platform will allow providers to validate the decrease in pain and improved quality of life."